December 20th 2024
Jason M Pogue, PharmD, BCPS, BCIDP discusses the findings, pharmacokinetics, why ceftolozane-tazobactam may be the preferred choice for resistant infections, and more.
November 11th 2024
Hand Hygiene Day: The Key to Fighting Antibiotic Resistance Is in Your Hands
May 5th 2017Today, May 5th, is Hand Hygiene Day, a day that reminds healthcare workers, visitors, and policy makers alike, that frequent handwashing can be used to fight the growing threat of antibiotic resistance, and ultimately, save millions of lives.
Read More
More Data is Needed to Help Guide Antibiotic Prescribing Practices in Dentistry
April 28th 2017Lauri A. Hicks, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses how more data is needed to provide dentists with better guidelines for prescribing antibiotics.
Watch
Nontraditional Interventions Can Enhance Antimicrobial Stewardship Programs
April 27th 2017Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, explains why stewards should think outside of the box when coming up with interventions to include in an antimicrobial stewardship program.
Watch
What Have We Learned About Ceftazidime-Avibactam?
April 16th 2017Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses the significance of the findings of her research on Ceftazidime-Avibactam.
Watch
The Importance of Rapid Diagnostic Testing
April 11th 2017Lilian Abbo, MD, chief, infection prevention & control and antibiotic stewardship, Jackson Health System, associate professor of clinical medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, explains the importance of rapid diagnostic testing.
Watch
Testing for C. difficile: What Are the Limitations?
April 8th 2017Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses limitations to C. difficile testing that could impact stewardship practices in healthcare facilities.
Watch
How to Be Smarter About Testing for C. difficile
April 3rd 2017Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, explains how to be more sensible when it comes to testing for Clostridium difficile.
Watch
"Make Antibiotics Great Again:" A Reflection on Antibiotic Stewardship
March 30th 2017Sara Cosgrove, MD, MS, current president of the Society for Healthcare Epidemiology of America (SHEA), painted a picture of the new landscape of antibiotic stewardship in the Opening Plenary of the 2017 SHEA Spring Conference held in St. Louis, Missouri.
Read More
Are Deadly Bacterial Infections Linked to Heavy Drinking?
March 17th 2017A study suggests that heavy drinkers receiving treatment injections for their condition may be more susceptible to acquiring an antibiotic-resistant infection with Anaerobiospirillum succiniciproducens, which can be fatal.
Read More
Patients with Beta-Lactam Allergy Need Unique Antimicrobial Stewardship
March 15th 2017On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers from Rush University presented findings on the efficacy of a new guideline, which aimed to detect whether self-reported beta-lactam allergies were, in essence, unpleasant side-effects to the drugs.
Read More
Schuchat Warns Loss of DHHS Fund Could Have Profound Impact on Infectious Disease Prevention
March 14th 2017It has been reported that the new healthcare reform bill could eviscerate the US Department of Health and Human Service’s Prevention and Public Health Fund, which, among other things, funds roughly 12% of the Centers for Disease Control and Prevention’s budget.
Read More
Beta-Lactam Allergy Linked to Worse Clinical Outcomes
March 13th 2017On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Gary Huang, MD, PhD, explained his research team's findings regarding self-reported allergy to drugs containing β-lactams.
Read More